Trials / Completed
CompletedNCT01232322
Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation
Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation for Long-term Use in Pediatrics
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 633 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 6 Months – 5 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and efficacy for long term treatment of the drug in children aged 6 months and \< 5 years on bronchial asthma in daily clinical usage.
Conditions
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2010-11-02
- Last updated
- 2013-01-24
Source: ClinicalTrials.gov record NCT01232322. Inclusion in this directory is not an endorsement.